**SpaceX IPO Volatility**
Space Exploration Technologies Corp. (SPCX) experienced significant volatility following its initial public offering, with shares surging 25% initially, raising Elon Musk’s net worth to over a trillion dollars, before dropping below $160 in the subsequent week. This led to most investors seeing losses and Musk’s return to hundreds of billions in net worth.
**Micron Technology’s Earnings Reaction**
Micron Technology Inc. (MU) saw a 15% drop amid a broader tech selloff, only to rebound sharply following strong earnings reports. This reflects ongoing volatility in the tech sector, driven in part by trading algorithms increasingly relying on similar data.
**Shifts in Drug Development**
Changes in U.S. drug development policies have become apparent, with HHS Secretary Robert F. Kennedy Jr. announcing intentions to revitalize American pharmaceutical innovation. Moderna Inc. (MRNA), known for its rapid COVID-19 vaccine development, is now seen as a strong candidate to benefit from renewed government support. Recent FDA backing for Moderna’s mRNA flu vaccine and successful growth in oncology therapies highlight its upward trajectory.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
